Bill Gates estimates the end of the coronavirus pandemic and warns that it will be different for rich and poor countries

The founder of Microsoft he is not optimistic about the possibility of an effective and preventive cure against the pandemic and risked that only one of the trials that are in the final phase could lead to true immunity.

Gates, who has donated millions of dollars in the development of a cure against the coronavirus, indicated that it is difficult for one to come to light before the end of the year and that if that happened only one of the candidates could reach the goal: Pfizer’s.

 
“The only vaccine that, if everything goes perfectly, could apply for the emergency use license at the end of October, would be that of Pfizer”, he concluded in a teleconference interview with the CNBC television network.

“I think once we get into, say, December or January, at least two or three are likely to seek approval, if they are really effective. And so we have these phase three trials that are ongoing. The only vaccine that, if everything goes perfectly, could request the emergency use license at the end of October, would be Pfizer ”, forecast.

The other two Gates refers to are the one developing the Modern company and the most widespread, that of the Oxford University -which yesterday announced that it was resuming the tests- in conjunction with the laboratory AstraZeneca.

 
Regarding the effectiveness of these vaccines, the president of the Gates Foundation – who leads together with his wife Melinda – was optimistic since they showed in the previous phases that he had developed immunity in the volunteers who underwent the experimental tests.

This foundation owns shares in Pfizer, but also in other companies that are developing vaccines, but in earlier stages, such as Johnson & Johnson and Merck.

Regarding the fears that arose from the fact that the doses could be approved before they are safe – as is the case in other countries – Gates was confident that the laboratory companies have already announced that they would not request authorization from the Food and Drug Administration (FDA, for its acronym in English) unless they are absolutely certain that they will not cause any harm to the body and will be effective against COVID-19.